Gabamide
Jump to navigation
Jump to search
| File:4-Aminobutyramide.png | |
| Clinical data | |
|---|---|
| Other names | GABAmide; GABAMIDE; GABA amide; 4-Aminobutanamide; 4-ABAD; 4-Aminobutyramide; gamma-Aminobutyramide; γ-Aminobutyramide; GABAD; gamma-Aminobutyric acid amide; γ-Aminobutyric acid amide |
| Drug class | GABA receptor agonist |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| E number | {{#property:P628}} |
| CompTox Dashboard (EPA) |
|
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 29: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C4H10N2O |
| Molar mass | 102.137 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Gabamide, or GABAmide, also known as γ-aminobutyramide (GABAD), is a GABA receptor agonist and GABA analogue, or more specifically the amide of the inhibitory neurotransmitter γ-aminobutyric acid (GABA).[1][2] Along with GABA and progabide acid (SL-75.102), gabamide is an active metabolite of the anticonvulsant drug progabide (Gabrene; SL-76.002).[1][2] Unlike progabide, but similarly to GABA, gabamide is unable to cross the blood–brain barrier and hence is peripherally selective.[2] However, gabamide and GABA are formed in the brain from progabide following its entry into this part of the body.[2]
See also
[edit | edit source]- γ-Amino-β-hydroxybutyric acid (GABOB)
- γ-Hydroxybutyrate (GHB)